ALB and neoplasm: Our results are coherent with previous report, where the conversion of crystalline lapatinib into amorphous form enhanced the solubility when encapsulated into poly(lactic-co-glycolic acid) (PLGA NPs) coated with albumin for tumor targeting [29].